Popular Articles

Cancer Research UK Aims For Positive End To 'Bad Day'
THIS month, Cancer Research UK is set to unveil a brand new national television ad campaign to raise awareness and increase donations for vital research into cancer.
pharmacy online
Sens. Continue To Press Sotomayor On Abortion Rights On Third Day Of Confirmation Hearings
In her third day of confirmation hearings before the Senate Judiciary Committee, Supreme Court nominee Sonia Sotomayor deflected lawmakers" attempts to elicit specific answers on how she would rule on abortion-rights cases and other contentious issues, the Washington Post reports (Goldstein et al., Washington Post, 7/16). As she entered what likely will be the final day of testimony on Thursday, Sotomayor"s confirmation "seemed on track," and Republicans appeared to be "conceding that they had not built the momentum necessary to derail the nomination," according to the New York Times, (Stolberg/Lewis, New York Times, 7/16). Cornyn Questions Abortion-Rights ViewsSen. John Cornyn (R-Texas) asked Sotomayor whether reports that Obama administration officials had sought to elicit her views on abortion were accurate. She responded that she "was asked no question by anyone including the president about my views on any specific legal issue" (Espo/Sherman, AP/Houston Chronicle, 7/15). Cornyn cited comments from George Pavia -- the senior partner at the New York law firm where Sotomayor previously worked -- who stated that he could "guarantee" that she would "be for abortion rights." Sotomayor said, "I have no idea why he"s drawing that conclusion," adding, "If he was talking about the fact that I served on a particular board that promoted equal opportunity for people, the Puerto Rican Legal Defense and Education Fund, then you could talk about that being a liberal instinct, in the sense that I promote equal opportunity in America and the attempts to ensure that." She continued, "But he has not read my jurisprudence for 17 years, I can assure you. He"s a corporate litigator. And my experience with corporate litigators is that they only look at the law when it affects the case before them" (Washington Post, 7/16). Sotomayor added that she "know[s] for a fact that I never spoke to [Pavia] on my views on abortion or my views on any social issue" (Bendavid, "Washington Wire," Wall Street Journal, 7/15). Sotomayor noted that she once ruled to uphold the "global gag rule," also known as the "Mexico City" policy, which barred federal funding of international family planning groups that provide abortion information or services (New York Times, 7/16).Coburn Presses on Hypothetical CasesDuring his questioning, Sen. Tom Coburn (R-Okla.) asked Sotomayor about hypothetical cases related to abortion-rights issues, including if it would be legal if a woman sought an abortion at 38 weeks" gestation if the fetus had spina bifida. Sotomayor said, "I can"t answer that question in the abstract, because I would have to look at what the state of the state"s law was on that question and what the state said with respect to that issue." She continued, "The question is, is the state regulation regulating what a woman does an undue burden? And so I can"t answer your hypothetical, because I can"t look at it as an abstract without knowing what state laws exist on this issue or not. And even if I knew that, I probably couldn"t opine, because I"m sure that situation might well arise before the court" (Holman, "NewsHour with Jim Lehrer," PBS, 7/15). Sotomayor also said that the Supreme Court"s 1992 ruling in Planned Parenthood v. Casey "reaffirmed the core holding of Roe v. Wade that a woman has a constitutional right to terminate her pregnancy in certain cases" (Hirschfeld Davis, AP/Boston Globe, 7/16). She added that the ruling said the court should consider whether any state regulation "has an undue burden on the woman"s constitutional right" (Sherman, AP/Sacramento Bee, 7/15). Coburn also asked whether medical advancements that help premature infants survive might "have any bearing on how we look at" Roe (Savage/Oliphant, Chicago Tribune, 7/16). She said, "I can"t answer that in the abstract," adding, "The question as it would come before me wouldn"t be in the way that you form it as a citizen, it would come to me as a judge" (AP/Houston Chronicle, 7/15).Specter Seeks Clarification on RoeDuring question
News of the day
One Force Behind The MYC Oncogene In Many Cancers Uncovered By Fox Chase Researchers
DLX5, a gene crucial for embryonic development, promotes cancer by activating the expression of the known oncogene, MYC, according to researchers from Fox Chase Cancer Center. Since the DLX5 gene is inactive in normal adults, it may be an ideal target for future anti-cancer drugs, they reason. Their findings are published in the July 31 edition of the Journal of Biological Chemistry, available online now.
Medical Devices

Impact Of Medicare Part D On Medical Spending Addressed By NEJM Study

After enrolling in Medicare Part D, seniors who previously had limited or no drug coverage spent more on prescriptions and less on other medical care services such as hospitalizations and visits to the doctor"s office, according to a University of Pittsburgh Graduate School of Public Health study. Published in the July 2 issue of the New England Journal of Medicine, the study also found that seniors who had relatively good drug benefits prior to enrolling in Medicare Part D spent somewhat more on prescriptions and, at the same time, increased their spending on other medical care services. "We found that Part D led to increases in overall pharmacy spending among all beneficiaries," said the study"s lead author, Yuting Zhang, Ph.D., assistant professor of health economics at the University of Pittsburgh Graduate School of Public Health. "These increases were offset by decreases in spending on other medical care services in those with little or no drug coverage before they enrolled in Medicare Part D, which was one-third of the beneficiary population studied. The majority of Part D enrollees in our study population - those with relatively good prior prescription coverage - spent more on prescriptions as well as other medical services." The purpose of Medicare Part D, which took effect in January 2006, is to subsidize the cost of prescription drugs for Medicare beneficiaries, more than 30 percent of whom had limited or no coverage for prescription drugs prior to its implementation. Dr. Zhang and her colleagues compared prescription drug use and other medical spending among three groups of senior citizens two years before and after Part D was implemented. The groups included beneficiaries with no prior drug coverage, poor prior drug coverage ($600 maximum per year) and relatively good prior drug coverage ($1,400 maximum per year, comparable to Part D). They found that total monthly prescription drug spending increased by 74 percent among the no-coverage group; by 27 percent among the poor-coverage group; and by 11 percent among the good-coverage group. The study also found that the use of both lipid-lowering and anti-diabetic medications rose in the groups with limited or no drug coverage. When it came to spending on other medical care services excluding drugs, the no-coverage group and poor-coverage group decreased their spending by $33 and $46 per month respectively, while the good-coverage group increased their spending by $30 per month. "The offset in spending by seniors with limited or no prior drug benefits could be due to improved adherence to medication, especially for those with chronic conditions. Improved access to prescription drugs provided by Part D may enable this population to better control symptoms and cut down on visits to the physician"s office or emergency room," said Dr. Zhang. On the other hand, the lack of a similar spending offset in the good-coverage group could indicate an overuse of some medications and services by this population, she noted. Co-authors of the study include senior author Joseph P. Newhouse, Ph.D., Harvard University; Julie M. Donohue, Ph.D., and Judith R. Lave, Ph.D., University of Pittsburgh Graduate School of Public Health; and Gerald O"Donnell, M.S., Highmark Inc., Pittsburgh. The study was funded in part by a grant to Dr. Donohue from the National Institutes of Health and a grant to Dr. Newhouse from the Alfred P. Sloan Foundation. Clare Collins University of Pittsburgh Schools of the Health Sciences


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):